Ireland Europe
FDF / DRUG PRODUCTS NUTRACEUTICALS PARTICLE ENGINEERING in Europe
Competence Center for spray drying and modified release pellets.
About the plant
The Aenova site in Killorglin has almost 50 years of experience in granulation, modified release coating, encapsulation, extraction and spray-drying.
As Competence Center for modified release pellets, our site in Killorglin produces and encapsulates particularly innovative types of pellets.
The spray drying development center continues to expand, providing a broad portfolio of applications, including solutions to enhance the bioavailability of APIs in oral solids.
More information here: Aenova Group
Compliance
- ISO
- EMA (EU GMP)
- MFDS/KFDA (Republic of Korea GMP)
- PMDA/MHLW (Japan GMP)
- SFDA (Saudi Food & Drug Authority)
- 14001
Activity
- Oral solids / OSD, Tablets, Hard capsules, Granules / Pellets, FDF / DRUG PRODUCTS, NUTRACEUTICALS, PARTICLE ENGINEERING manufacturing
Features
- Uses: Commercial (Phase IV), Human, Veterinary
- Toxicity (OEB classification): 1 / low-hazard (PDE > 5,000 µg/day), 2 (PDE = 1,000 - 5,000 µg/day), 3 (PDE = 100 - 1,000 µg/day)
- Controlled substance: N/A
- BSL: N/A
- Therapeutic areas: N/A
- Markets: EMA (EU), PMDA (Japan), MFDS (South Korea), SFDA (Saudi Arabia)
Batch Size / Reactor
- Small, Medium, Large
Services
- Development services, Manufacturing services, Analytical / QC services, Quality Assurance services, Packaging, Tech transfer, Scale-up
Other plants of this company
FDF / DRUG PRODUCTS NUTRACEUTICALS in Europe Competence Center and one-stop shop for Soft gelatin capsules and VegaGels®.
FDF / DRUG PRODUCTS in Europe Competence Center low-dosed high potent solids (hormones, hormone-like), low-dosed capsules.
FDF / DRUG PRODUCTS in Europe Competence center for conventional solids and clinical services.
